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Comparison of anesthesia with sevoflurane-N2O and
midazolam-remifentanil in low-birth-weight premature infants
undergoing diode laser photocoagulation
Abdulkadir BUT1, Müge ARIKAN2, Bilge ASLAN2, Levent ÖZTÜRK1, Meltem TABUK2, Eyüp HORASANLI2

Aim: The present study aimed to compare anesthesia with sevoflurane-N2O and midazolam-remifentanil in terms
of hemodynamic parameters and safety in low-birth-weight (LBW) premature infants undergoing diode laser
photocoagulation (DLP) for retinopathy of prematurity (ROP).
Materials and methods: A total of 91 infants undergoing DLP for ROP were enrolled in this study. All of the infants
were established with LBW (<2000 g) and were preterm (gestational age of <32 weeks; age range: 0-28 days). The infants
were intubated in the neonatal intensive care unit (NICU) and were randomly divided into 2 groups. For Group 1 (n =
47), anesthesia was induced with 45% O2 + 55% N2O + 3%-5% sevoflurane to which 1 μg kg–1 fentanyl was added, and
it was then maintained with 45% O2 + 55% N2O + 1%-3% sevoflurane. For Group 2 (n = 44), anesthesia was induced
with 0.1 mg kg–1 midazolam + 2 μg kg–1 remifentanil, and it was then maintained with a concomitant infusion of 0.1-0.2
mg kg–1 h–1 midazolam + 0.125-0.2 μg kg–1 min–1 remifentanil. Hemodynamic data, perioperative complications, and
extubation time were recorded. The patients were transported to the NICU in the postoperative period without being
extubated.
Results: No significant differences were observed between the groups in terms of demographic data, perioperative
complications, and extubation time. Heart rate values were significantly lower in both groups at different measurement
times with respect to baseline values. Mean arterial pressure values were significantly higher in Group 1 only at 60 min
in comparison to Group 2.
Conclusion: Anesthesia with sevoflurane + O2 + N2O and with remifentanil + midazolam were established to be safe
anesthetic approaches for LBW premature infants.
Key words: Retinopathy of prematurity, sevoflurane, midazolam, remifentanil

Diod lazer fotokoagülasyon uygulanan düşük doğum ağırlıklı prematürelerde
sevofluran-N2O ve midazolam-remifentanil anestezisinin karşılaştırılması
Amaç: Bu çalışmada premature retinopatisi (ROP) nedeniyle diod lazer fotokoagülasyon (DLP) uygulanacak düşük
doğum ağırlıklı premature yenidoğanlarda; sevofluran-N2O ve midazolam-remifentanil anestezisinin hemodinamik
parametreler ve güvenlik açısından karşılaştırılması amaçlanmıştır.
Yöntem ve gereç: Çalışmaya ROP nedeniyle DLP uygulanacak yaşları 0-28 gün arasında olan, ağırlığı 2000 g’ın altında
ve gestasyonel yaşı 32 haftadan az olan 91 yenidoğan dahil edildi. Hastalar; Neonatal Yoğun Bakım Ünitesinde (NYBÜ)
elektif şartlarda deneyimli pediyatri uzmanları tarafından entübe edildikten sonra ameliyathaneye alındılar ve rasgele
yöntemle iki gruba ayrıldılar. Grup 1’de (n = 47) anestezi indüksiyonu; % 45 O2 + % 55 N2O + % 3-5 sevofluran ile
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gerçekleştirildi ve 1 μg kg–1 fentanil eklendi. Anestezi idamesi % 45 O2 + % 55 N2O + % 1-3 sevofluran ile sağlandı. Grup
2’de (n = 44) anestezi indüksiyonu 0.1 mg kg–1 midazolam + 2 μg kg–1 remifentanil ile gerçekleştirildi ve anestezi idamesi
0.1-0.2 mg kg–1 h–1 midazolam + 0.125-0.2 μg kg–1 min–1 remifentanil ile sağlandı. Hemodinamik veriler, perioperatif
komplikasyonlar ve ekstübasyon süreleri kaydedildi. Tüm olgular operasyon sonunda entübe olarak NYBÜ’ye nakledildi.
Bulgular: Her iki grup arasında demografik veriler, peroperatif gelişen komplikasyon sayıları ve ekstübasyon süreleri
açısından istatistiksel olarak fark saptanmadı. Kalp hızı değerlerinde her iki grupta da giriş değerlerine göre farklı ölçüm
zamanlarında düşüşler gözlendi. Gruplar arası değerlendirmede; ortalama arter basıncı sadece 60. dakikada Grup 1’de
Grup 2’ye göre yüksek saptandı.
Sonuç: Düşük doğum ağırlıklı premature yenidoğanların anestezisinde sevofluran + O2 + N2O ve remifentanil +
midazolam tekniklerinin her ikisinin de güvenle kullanılabileceği kanısındayız.
Anahtar sözcükler: Prematüre retinopatisi, sevofluran, midazolam, remifentanil

Introduction

Materials and methods

Retinopathy of prematurity (ROP) is one of the
leading causes of childhood blindness, requiring
immediate surgical intervention. A number of factors
have been associated with ROP, such as gestational
age, sepsis, hypotension, hypoxia, apnea requiring
ventilation, and hypercapnia/hypocapnia. However,
the most important factor has been reported to be
incomplete retinal maturation. While the incidence
of ROP in premature infants was reported to be 5%6.4% in developed countries, it is as high as 19%65.8% in developing countries. The increase in ROP
surgery has been associated with advances in neonatal
care and improved survival rates of premature infants
(1-4).

Following the approval of the ethics committee,
we enrolled 91 premature infants designated to
undergo DLP for ROP between 2008 and 2010.
All of the premature infants were established with
LBW (<2000 g) and were preterm (gestational age
of <32 weeks; age range: 0-28 days). Neonates were
excluded from the study if they had congenital heart
disease, hemodynamic instability before intubation,
or symptomatic central nervous system disease.
The premature infants were followed up with in our
newborn intensive care unit (NICU). They were
evaluated preoperatively and informed consent was
obtained from their families.

Currently, cryotherapy and diode laser
photocoagulation (DLP) are the 2 approaches utilized
in the treatment of ROP. Analgesia and immobility
have critical roles in the success of surgery. The
extremely sensitive nature of newborn anatomy
and physiology warrant particular care during
anesthesia and surgery. Moreover, prematurity and
low birth weight (LBW) further complicate the issue.
There is an increased likelihood of life-threatening
complications such as oxygen desaturation, apnea,
severe bradycardia, or cardiovascular arrest in the
perioperative stage of LBW infants. However, no
consensus has been reached so far regarding the ideal
anesthetic approach to be employed for infants (4-6).
The aim of the present study was to compare
anesthesia with sevoflurane-N2O and midazolamremifentanil in terms of hemodynamic parameters
and safety in LBW premature infants undergoing
DLP for ROP.
574

The premature infants were administered 0.1
mg kg–1 midazolam and intubated by experienced
pediatricians before being taken to the operating
room in the NICU.
Anesthesia monitoring included electrocardiography (ECG), pulse oximetric saturation (SpO2),
heart rate (HR), and mean arterial blood pressure
(MAP). The patients were randomly allocated into
Group 1 (n = 47) or Group 2 (n = 44) using a random
number table. The drugs were prepared by a team
member not involved in data recording. Anesthesia
was induced with 45% O2 + 55% N2O + 3%-5%
sevoflurane to which 1 μg kg–1 fentanyl was added,
and then it was maintained with 45% O2 + 55% N2O
+ 1%-3% sevoflurane for Group 1. For Group 2,
anesthesia was induced with 0.1 mg kg–1 midazolam
+ 2 μg kg–1 remifentanil, and then it was maintained
with concomitant infusion of 0.1-0.2 mg kg–1 h–1
midazolam + 0.125-0.2 μg kg–1 min–1 remifentanil
and 45% O2 + 55% air. In both groups, the dosage

A. BUT, M. ARIKAN, B. ASLAN, L. ÖZTÜRK, M. TABUK, E. HORASANLI

of agents used during the maintenance of anesthesia
was applied between the concentrations mentioned
above based on the anesthetic depth required to
achieve immobility considering the intraoperative
hemodynamic parameters.
The body temperature of the premature infants
and the operating room temperature were maintained
by peripheral heaters. The fluid management in the
patients was standardized by heated mix fluids at
5-10 mL h–1.
SpO2, HR, and MAP values were recorded at 5-min
intervals intraoperatively and at elapsed time intervals
from the discontinuation of anesthetic to the time
of extubation. The weight of the infants, gestational
age, American Society of Anesthesiologists (ASA)
physical status scores, and the operation time were
all recorded, as well.
Complications such as bradycardia, desaturation,
hypotension, and endotracheal tube malposition
and their occurrences were noted. Bradycardia was
defined as HR < 90 beats/min, desaturation as SpO2 <
90%, and hypotension as systolic blood pressure < 45
mmHg. Bradycardia was treated by the administration
of atropine (0.015 mg kg–1), desaturation by increasing
the inspired O2 concentration, and hypotension by
decreasing the anesthetic drug concentration.
After the surgical procedure, the anesthetic agents
were discontinued and the patients were transferred,
without being extubated, to the NICU accompanied
by anesthesiologists, and mechanical ventilation was

initiated and adjusted. Extubation was performed
when the patient met the adequate ventilatory
parameters in the NICU, and the extubation time was
recorded.
Statistical analyses were performed using SPSS
17.0 (SPSS Inc., Chicago, IL, USA). The results
were expressed as mean ± standard deviation (SD).
Student’s t-test was used for the comparisons between
the groups. The paired samples t-test was performed
on the hemodynamic parameters for repeated
measures. Pearson’s correlation analysis was used to
demonstrate the correlation between the duration of
the operation and the time to extubation. P <0.05 was
considered statistically significant for all analyses.
Results
The demographic data and the time to extubation
for both groups are given in Table 1. No significant
differences were observed between the groups.
The following perioperative complications were
observed: bradycardia in 5 patients in Group 1 and
4 patients in Group 2, bradycardia + hypotension in
3 patients in Group 1 and 3 patients in Group 2, and
transient desaturation in 3 patients in Group 1 and
4 patients in Group 2. Malposition in endotracheal
intubation was seen in one patient due to the change
of the position of the patient’s head by the surgeon,
and the patient was reentubated. No differences
were observed between the groups in terms of
perioperative complications (Table 2).

Table 1. Demographic data and extubation time.
Group 1 (n = 47)

Group 2 (n = 44)

28.26 ± 2.15

28.77 ± 2.42

1182.7 ± 329.7

1235.2 ± 338.4

ASA status

2.32 ± 0.6

2.36 ± 0.6

Operation time (min)

74.7 ± 10.7

77.8 ± 10.8

Extubation time (h)

9.44 ± 3.62

10.13 ± 3.32

Gestational age (weeks)
Birth weight (g)

Note: Data are means ± SDs.

575

Sevoflurane-N2O and midazolam-remifentanil in LBW infants

Table 2. Intraoperative complications.
Group 1 (n = 47)

Group 2 (n = 44)

Bradycardia (n)

5

4

Temporary desaturation (n)

3

4

Bradycardia + hypotension (n)

3

3

The 2 groups were similar in terms of extubation
time. There was no correlation between the duration
of operation and extubation time.

HR (beats/min)

MAP values were significantly higher in Group 1
at 10, 20, 30, and 40 min and in Group 2 at 30 and
40 min in comparison to the baseline value (P <
0.05). MAP values were significantly higher in Group
1 only at 60 min in comparison to Group 2. HR
values were significantly lower in Group 1 at all of
the measurement times and in Group 2 at 20, 30, 40,
50, and 60 min in comparison with the baseline value
(P < 0.05). No significant changes in HR values were
observed between the groups. A significant difference
was observed in the SpO2 value at 30 min, which was
lower in Group 2 when compared with that observed
in Group 1.
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Figure 2. Heart rate (HR).
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Intraoperative changes in HR, MAP, and SpO2 are
shown in Figures 1-3.
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Figure 1. Mean arterial pressure (MAP).
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Discussion
In this study, we observed similar hemodynamics,
intraoperative complications, and extubation times
with both the sevoflurane-N2O and midazolamremifentanil methods during this type of surgery.
Both of these anesthetic methods can be used safely
in this type of operation by taking into consideration
the anatomic and physiologic properties of the
patients.
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The early diagnosis and treatment of ROP plays
a critical role in preventing blindness, and, contrary
to common belief, treatment procedures are painful.
It has been well established that premature infants
feel pain. Therefore, immobility and analgesia are
of major importance in increasing the success of
surgery (7,8).
A number of methods, such as topical anesthesia,
sedation, or general anesthesia, can be utilized
during ROP surgery. It is recommended that infants
be intubated and ventilated under elective conditions
before laser treatment so as to control their airways
and avoid surgical stress (8,9). That is why, in the
current study, the patients were intubated before
entering the operation room, and then general
anesthesia was maintained and controlled mechanical
ventilation was initiated.
The evaluation of preoperative systemic functions,
birth weight, and gestational age, as well as the
determination of ASA classification before general
anesthesia, are critical in terms of the establishment
of intraoperative strategies (6). Litman et al. (10)
reported that although postoperative complications
were directly associated with ASA scores and body
weight in preterm and term neonates, no correlation
was established with gestational age. Preoperative
evaluation of ASA scores and body weight in
the present study revealed increased likelihood
of intraoperative complications. However, the
number of intraoperative complications observed
in our patients was within the acceptable range. The
duration of anesthesia increases the existing risks
in preterm and LBW infants, as well. In the current
study, the mean duration of operation was 74.7 ± 10.7
min in Group 1 and 77.8 ± 10.8 min in Group 2 as
all patients underwent DLP, and these findings were
consistent with those observed in similar studies in
the literature (11).
Optimizing the drug dosage required for
anesthetic depth and hemodynamic stability
during anesthesia is of critical importance in terms
of avoiding complications in premature infants.
Frequent problems during anesthesia for infants
are LBW, hypothermia, concomitant pulmonary
diseases, metabolic problems, immature receptors,
and alterations in the cerebral blood flow. Maintaining
hemodynamic stability during anesthesia is also

critical, as tachycardia, hypotension, or hypertension
can lead to elevated perioperative cardiac morbidity
(12). It has to be remembered that inadequate
depth of anesthesia will lead to a marked increase
in the stress response of the infant to surgical
trauma. A number of studies have been carried out
to investigate different kinds of combinations of
agents for general anesthesia in LBW infants. In a
study including 72 infants who were administered
a combination of inhalatory sedation and topical
anesthesia, Ferrer Novella et al. (13) concluded that
inhalatory gases could be safely used in this patient
group. Yavaşcaoğlu et al. (14) reported that the
retrospective evaluation of patients treated with laser
photocoagulation for ROP revealed no significant
differences in terms of hemodynamic parameters
and complications in groups administered different
agents, such as sevoflurane, ketamine, and fentanyl,
for the induction and maintenance of anesthesia.
Davis et al. (15) reported that the combination of
remifentanil with N2O and O2 could be used safely
in infants under 2 months of age, as well as in infants
who are to be extubated in the postoperative period.
The results of the present study were consistent with
the data reported in those studies. However, to the
best of our knowledge, the current study presents
the largest study sample among similar studies
comparing inhaled and intravenous anesthetic agents
in LBW infants.
In newborn anesthesia, intravenous agents are
used in conjunction with inhalation agents. The
intravenous use of ketamine, benzodiazepines,
alpha-2 agonists, and opioids reduce the requirement
for inhalation anesthetics (12).
Remifentanil has become a popular agent in
recent years because of its short effecting time,
organ-free breakdown, and suppressive effects on
the hemodynamic response. The ideal infusion rate
to maintain hemodynamic stability in infants was
reported as 0.25 μg kg–1 min–1 (15,16).
Midazolam is another agent that has been used
in infants for sedation and anesthesia (17,18).
Sammartino et al. (18) induced anesthesia with
0.20 mg kg–1 midazolam and followed up with 3-5
μg kg–1 min–1 remifentanil infusion in preterm
infants undergoing DLP for ROP. They reported
the technique to be safe. In the current study, we
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observed similar results in our patients in Group 2
and achieved the required hemodynamic target.
In a retrospective study conducted by Yavaşcaoğlu
et al. (14), patients undergoing laser treatment
for ROP were administered ketamine, fentanyl,
sevoflurane, and mivacurium or rocuronium as a
myorelaxant for endotracheal intubation. In their
sample of 32 patients, they reported the most common
complication to be apnea (7 cases, 17.5%), followed
by convulsion (2 cases, 5%), desaturation (2 cases,
5%), and bradyarrhythmias (1 case, 2.5%). Litman
et al. (10) investigated the risk of apnea following
general anesthesia in term and preterm infants
and showed that the risk was correlated with body
weight, ASA status, and apnea history. Aoyama et al.
(11) used fentanyl and sevoflurane anesthesia in DLP
treatment and reported only one patient with upper
airway obstruction leading to pulmonary edema.
They emphasized that despite the associated high
risks, anesthesia could be managed successfully in
these patients by planning the anesthesia thoroughly,

taking the necessary precautions, and intervening
promptly when complications arose. The evaluation
of the complication incidences in the present study
revealed that our results were consistent with those
observed in similar studies in the literature.
In our study, times to extubation in both groups
were similar. Anesthetic protocol is an important
factor for time to extubation in these patients;
however, extubation times are even more dependent
on the preclinical conditions of the infants (19). On
the other hand, we did not find a positive correlation
between duration of operation and time to extubation.
In conclusion, comparing the sevoflurane-N2O
and the midazolam-remifentanil anesthesia in LBW
premature infants undergoing DLP for ROP, we found
that the hemodynamic responses, intaroperative
complications, and extubation times in both groups
were similar and clinically acceptable. We suggest
that both of these techniques can be used safely for
LBW premature infants.
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